Dry Eye Syndrome (DES) Drugs Market: Population Aging to Create Opportunities: Recent Press Release Update by MarketResearchReports.Biz

Albany, NY -- (SBWIRE) -- 03/07/2016 -- Keratoconjunctivitis sicca is a condition that arises when the eye is not able to produce enough tears or any tears produced evaporate quickly. The condition occurs among humans but is also observed to affect some animals. It is due to these attributes of the condition that it is also referred to as the dry eye syndrome (DES). Medical practitioners say that this is the most common type of eye disease, with prevalence rising in postmenopausal women and the elderly. Being a disease with such a widespread prevalence, there is a correspondingly high demand for drugs and therapies to treat the dry eye syndrome. A new report that is now available on the website of MarketResearchReports.biz, titled 'PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Assessment To 2024,' studies this market in detail. The report will help readers track sales of dry eye syndrome therapeutics worldwide during the period from 2014-2024.